Medtronic's (MDT) StealthStation Cranial Software Cleared by FDA

September 26, 2016 8:02 AM EDT Send to a Friend
Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) clearance of StealthStation® Cranial Software as an aid ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login